dihexa human studies clinical trials status dosage trial Dihexa shows neurotrophic activity exceeding BDNF in preclinical DIHEXA dihexa human studies clinical trials

BPC-157 is a synthetic 15-amino-acid pentadecapeptide (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val), a partial sequence of the Body Protection Compound found in gastric juice

A brief consultation with our in house MD ensures your health history is reviewed to tailor the treatment to your specific needs

Clinical trial results showed modest and variable weight loss outcomes

P.Sikiric, M.Petek, R.Rucman et al, A new gastric peptide BPC an overview of stomach/ stress/ organoprotective hypothesis and BPC beneficial effects, J.Physiol

However, it is unknown if they are permanent, whether the organism may develop tolerance to the peptide, and what may happen to the results after stopping the treatment

But, how exactly does BPC-157 work, and is it safe